Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint Announces Non-Brokered Convertible Debenture Private Placement

TheNewsWire 7 days ago

Ventripoint Diagnostics Provides Corporate Update and Announces Conference Call

TheNewsWire March 28, 2024

Enhanced Design Breakthrough Makes Ventripoint's VMS+ Even Simpler to Use

TheNewsWire March 4, 2024

Ventripoint Successfully Showcases A.I.-Powered Heart-Scanning Technology at Prestigious International Cardiology Conferences

TheNewsWire February 20, 2024

Ventripoint Welcomes Bart Hendriks as New Strategic Partnerships Executive to Accelerate European and Global Sales

TheNewsWire February 13, 2024

Ventripoint Announces Changes to The Board of Directors

TheNewsWire February 13, 2024

Ventripoint Begins 2024 with Leadership Change

TheNewsWire February 5, 2024

The Medical University of Vienna's Paediatric Heart Centre Purchases Ventripoint's AI-Powered Heart Imaging System

TheNewsWire February 1, 2024

The 2023 Year in Review

TheNewsWire January 29, 2024

Dr. Luc Mertens, Head of Echocardiography at The Hospital for Sick Children, Joins Ventripoint's Clinical Advisory Board

TheNewsWire January 21, 2024

Ventripoint Whitepaper Distribution:

TheNewsWire January 3, 2024

ASCEND Cardiovascular to Market and Distribute Ventripoint's AI-powered Heart-Scanning Technology to North American Hospitals and Clinics

TheNewsWire December 12, 2023

Ollie Hinkle Heart Foundation will Introduce Ventripoint's AI-Heart-Imaging Diagnostic Technology to America's Hospitals

TheNewsWire December 5, 2023

Ventripoint Diagnostics Reports Third Quarter 2023 Financial Results

TheNewsWire November 29, 2023

Ventripoint Announces Date and Timing for Release of Q3 2023 Financial Results and Webinar

TheNewsWire November 24, 2023

Ventripoint to Demonstrate AI-powered Heart Imaging Technology at The British Congenital Cardiac Association Annual Conference

TheNewsWire November 9, 2023

Ventripoint Diagnostics Reports Results of Annual General & Special Shareholders Meeting

TheNewsWire November 3, 2023

Ventripoint to Hold Annual General Meeting of Shareholders on November 1, 2023

TheNewsWire October 24, 2023

Ventripoint AI Heart Imaging Technology To Be Presented at British Society of Echocardiography Annual Conference

TheNewsWire October 12, 2023

Ventripoint Announces Appointment of Chief Finance Officer

TheNewsWire October 3, 2023